期刊文献+

高剂量化疗和自体干细胞移植治疗T细胞淋巴瘤的疗效比较 被引量:1

原文传递
导出
摘要 T细胞淋巴瘤是T淋巴细胞来源的一类有着不同生物学行为和临床过程的异质性疾病,与B细胞非霍奇金淋巴瘤相比,其表现为侵袭性强,化疗敏感性差,易复发,预后不良。目前,T细胞淋巴瘤的治疗仍处于探索阶段,尚无统一、标准的治疗方法,而自体干细胞移植和高剂量化疗可能是目前治疗T细胞淋巴瘤的两种较好方法。
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2010年第4期298-299,共2页 Chinese Journal of Oncology
基金 江苏省医学领军人才培养项目(LJ200626)
关键词 淋巴瘤 T细胞 造血干细胞移植 药物疗法 联合 Lymphoma, T-cell Hematopoietic stem cell transplantation Drug therapy, combination
  • 相关文献

参考文献7

  • 1Gisselbrecht C,Gaulard P,Lepage E,et al.Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas.Croupe d'Etude des lymphomes agressives(GELA).Blood,1998,92:76-82.
  • 2Mercadal S,Briones J,Xicoy B,et al.Intensive chemotherapy(high-dose CHOP/ESHAP regimen)followed by autologous stemcell transplantation in previously untreated patients with peripheral T-cell lymphoma.Ann Oncol,2008,19:958-963.
  • 3侯军,章卫平,邱慧颖,郑晓丽,王利平,倪雄,宋献民,王健民.自体外周血干细胞移植治疗T细胞淋巴瘤的临床研究[J].临床肿瘤学杂志,2009,14(2):102-105. 被引量:12
  • 4黄晓春,李晓林,黄然欣,金香淑.73例外周T细胞淋巴瘤患者临床特征及预后分析[J].中南大学学报(医学版),2008,33(2):151-155. 被引量:13
  • 5Kim HJ,Bang SM,Lee J,et al.High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma:a retrospective comparison with non-transplantation cases.Bone Marrow Transpl,2006,37:819-824.
  • 6Rodríguez J,Caballero MD,Gutierrez A,et al.High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma:the GEL-TAMO experience.Ann Oncol,2003,14:1768-1775.
  • 7Gill S,Lane SW,Crawford J,et al.Prolonged haematological toxicity from the hyper-CVAD regimen:manifestations,frequency,and natural history in a cohort of 125 consecutive patients.Ann Hematol,2008,87:727-734.

二级参考文献25

  • 1张淑红,周小鸽,张彦宁,王鹏,张长淮,黄受方.T和NK细胞淋巴瘤152例病理学特点及类型构成分析[J].诊断病理学杂志,2006,13(3):190-193. 被引量:13
  • 2Fernandez HF, Escalon MP, Pereira D, et al. Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road? [ J ]. Bone Marrow Transplant, 2007,40 ( 6 ) : 505 -513.
  • 3Song KW, Mollee P, Keating A, et al. Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma:variable outcome according to pathological subtype [ J ]. Br J Haemato1,2003 ,120 :978 - 985.
  • 4Sehmitz N, Buske C, Gisselbrecht C. Autologous stem cell transplant-ation in lymphoma[ J]. Semin Hemato1,2007,44(4 ) :234 - 245.
  • 5Rodriguez J, Caballero MD, Gutierrez A, et al. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy [ J ]. Hematology, 2003, 88:1372 - 1377.
  • 6Rodriguez J, Caballero MD, Gutierrez A, et al. High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience[ J]. Ann Oncol ,2003,14 : 1768 - 1775.
  • 7Blystad AK, Enblad G, Kvaloy S, et al. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas [ J]. Bone Marrow Transplant, 2001,27 : 711 -716.
  • 8Rodriguez J, Munsell M, Yazji S, et al. Impact of high-dose chemotherapy on peripheral T-cell lymphomas[ J]. J Clin Oncol, 2001,19:3766 -3770.
  • 9Chen AI, McMillan A, Negrin RS, et al. Long-term results of autolngous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience [ J]. Biol Blood Marrow Transplant,2008,14 ( 7 ) :741 - 747.
  • 10Sweetenham JW, Santini G, Qian W, et al. High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/ maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma : results of a randomized trial of the European Group for Blood and Marrow Trans- plantation and the United Kingdom Lymphoma Group[ J]. J Clin Onco1,2001,19 :2927 - 2936.

共引文献17

同被引文献8

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部